| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.25 | 8e-05 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |